Tafasitamab and Lenalidomide in Relapsed/Refractory Large B Cell Lymphoma (R/R LBCL): Real World Outcomes in a Multicenter Retrospective Study
暂无分享,去创建一个
V. Seshan | P. Caimi | M. Okwali | B. Kahl | S. Rutherford | K. Maddocks | L. Leslie | C. Batlevi | D. Bond | Jason T. Romancik | Phuong H Dao | G. Wehmeyer | Mwanasha H Merrill | Michael J. Buege | G. Salles | J. Crombie | D. Qualls | Behzad Amoozgar